Proteosome delivery of a protective 9B-antigen against Schistosoma mansoni

International Journal of Immunopharmacology

Volumn 21, Issue 3, 1999, Pages 205-218

  Tarrab Hazdai, R ^a   Schechtman, D ^a   Lowell, G ^a   Pirak, E ^a   Arnon, R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; PROTEASOME; SCHISTOSOMA VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ARTICLE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMULUM; TRANSMISSION ELECTRON MICROSCOPY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, HELMINTH; BACTERIAL PROTEINS; CHRONIC DISEASE; COMPLEMENT SYSTEM PROTEINS; CYSTEINE ENDOPEPTIDASES; HUMANS; IMMUNE SERA; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICROSCOPY, IMMUNOELECTRON; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES;

EID: 0033003069     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00083-6     Document Type: Article

References (29)

1. Arnon, R. (1991). Immuno-parasitological parameters in schistosomiasis - a perspective view of a vaccine-oriented immunochemist. Vaccine, 9, 379-394.
2. Bergquist, N. R. (1995). Controlling schistosomiasis by vaccination: A realistic option? Parasitology Today, 11, 191-194.
3. Fallon, P. G., Sturrock, R. F., Niang, A. C., and Doenhoff, M. J. (1995). Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am. J. Trop. Med. Hyg., 53, 61-62.
4. Fishelson, Z. (1989). Complement and parasitic trematodes. Parasitology Today, 5, 19-25.
5. Fishelson, Z., Parizade, M., Ghendler, Y., and Arnon, R. (1990). Complement and Schistosoma mansoni. Complem. Inflamm., 7, 123. (Abst.).
6. Hawn, T. R., and Strand, M. (1994). Developmentally regulated localization and phosphorylation of SmIrV1, a Schistosoma mansoni antigen with similarity to calnexin. J. Biol. Chem., 269, 20083-20089.
7. Hawn, T. R., Tom, T. D., and Strand, M. (1993). Molecular cloning and expression of SmIrV1, a Schistosoma mansoni antigen with similarity to calnexin, calreticulin, and OvRaI1. J. Biol. Chem., 268, 7692-7698.
8. Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L. F., and Bennett, J. L. (1996). Characterization of isolates of Schistosoma mansoni from Egyptian villager that tolerate high doses of praziquantel. Am. J. Trop. Mod. Hyg., 55, 214-218.
9. Koster, B., and Strand, M. (1994). Schistosoma mansoni: Sm23 is a transmembrane protein that also contains a glycosylphosphatidylinositol anchor. Arch. Biochem. Biophys., 310, 108-117.
10. Levi, R., Aboud, P. E., Leclerc, C., Lowell, G. H., and Arnon, R. (1995). lntranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine, 13, 1353-1359.
11. Levi-Schaffer, F., Tarrab-Hazdai, R., Schryer, M. D., Arnon, R., and Smolarsky, M. (1984). Isolation and partial characterization of the tegumental outer membrane of schistossomula of Schistosoma mansoni. Mol. Biochem. Parasitol., 13, 283-300.
12. Lowell, G. H., Ballou, W. R., Smith, L. F., Wirtz, R. A., Zollinger, W. D., and Hockmeyer, W. T. (1988a). Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science , 240, 800-802.
13. Lowell, G. H., Smith, L. F., Seid, R. C., and Zollinger, W. D. (1988b). Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. J. Exp. Med., 167, 658-663.
14. Lowell, G. H. (1990). Proteosome, hydrophobic anchors, ISCOMS, and liposomes for improved presentation of peptide and protein vaccines. In G. C. Woodrow and M. M. Levine (Eds.), New Generation Vaccines (pp. 141-160). New York: Marcel Decker, Inc.
15. Marikovsky, M., Levi-Schaffer, F., Arnon, R., and Fishelson, Z. (1986). Schistosoma mansoni: killing of transformed schistosomula by the alternative pathway of complement. Exp. Parasitol., 61, 86-94.
16. Marikovsky, M., Parizade, M., Arnon, R., and Fishelson, Z. (1990). Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni. Eur. J. Immunol., 20, 221-227.
17. Mendlovic, F., Tarrab-Hazdai R., Puri, J., and Arnon, R. (1989) Genetic control of immune response to a purified Schistosoma mansoni antigen. I. Effect of MHC class II antigens on the cellular, humoral and protective responses. Parasite Immunol., 11, 667-682.
18. Pierce, S. K., and Klinman, N. R. (1967). Allogenic carrier specific enhancement of hapten-specific secondary B-cell responses. J. Exp. Med., 114, 1254-1261.
19. Ramalho-Pinto, F. J., de Rossi, R., and Smithers, S. R. (1979). Murine schistosomiasis mansoni: anti-schistosomula antibody and the IgG sub-classes involved in the complement- and eosinophil- mediated killing of schistosomula in vitro. Parasite Immun., 1, 2295-2308.
20. Reynolds, S. R., Schoemaker, C. B., and Harn, D. A. (1992). T and B Cell Epitope Mapping of SM23. An Integral Membrane Protein of Schistosoma mansoni. J. Immunol., 149, 3995-4001.
21. Savioli, I., Renganathan, E., Montresor, A., Davis, A., and Behbehani, K. (1997). Control of Schistosomiasis - A global picture. Parasitology Today, 13, 444-448.
22. Simpson, A. J., Hackett, F., Kelly, C., Knight, M., Payares, G., Omer-Ali, P., Lillywhite, J., Fleck, S. L., and Smithers, S. R. (1986). The recognition of Schistosoma mansoni surface antigens by antibodies from patients infected with S. mansoni and S. haematobium. Trans. R. Soc. Trop. Med. Hyg., 80, 261-270.
23. Smithers, S. R., and Terry, R. J. (1965). The infection of laboratory hosts with cercariae of S. mansoni and the recovery of adult worms. Parasitology, 55, 695-700.
24. Soisson, L. M., Masterson, C. P., Tom, T. D., McNally, M. T., Lowell, G. H., and Strand, M. (1992). Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J. Immunol., 49, 3612-3620.
25. Strand, M., Dalton, J. P., and Tom, T. D. (1987). Characterization and cloning of Schistosoma mansoni immunogens recognized by protective antibodies. Acta Trop. Suppl., 12, 75-82.
26. Tarrab-Hazdai, R., Levi-Schaffer, F., Brenner, V., Horowitz, S., Eshhar, Z., and Arnon, R. (1985). Protective monoclonal antibodies against Schistosoma mansoni antigen isolation, and suitability for active immunization. J. Immunol., 135, 2772-2779.
27. Tokuyasu, K. T., and Singer, S. J. (1976). Improved procedures for immunoferritin labeling of ultrathin frozen sections. J. Cell Biol., 71, 894-906.
28. Wilkins, H. A., and Moore, P. J. (1987). Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia. J. Trop. Mad. Hyg., 90, 83-92.
29. Zollinger, W. D., Mandrell, R. E., Griffiss, J. M., Altieri, P., and Berman, S. (1979). Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Inv., 63, 836-846.